Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625001456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849470210298347520 |
|---|---|
| author | Nika Kotnik, MD Gilles F.H. Diercks, MD, PhD Hilde Jalving, MD, PhD Geke A.P. Hospers, MD, PhD Sjoukje F. Oosting, MD, PhD Michel van Kruchten, MD, PhD T. Jeroen N. Hiltermann, MD, PhD Maria C. Bolling, MD, PhD Jeroen Bremer, PhD Barbara Horváth, MD, PhD Joost M. Meijer, MD, PhD |
| author_facet | Nika Kotnik, MD Gilles F.H. Diercks, MD, PhD Hilde Jalving, MD, PhD Geke A.P. Hospers, MD, PhD Sjoukje F. Oosting, MD, PhD Michel van Kruchten, MD, PhD T. Jeroen N. Hiltermann, MD, PhD Maria C. Bolling, MD, PhD Jeroen Bremer, PhD Barbara Horváth, MD, PhD Joost M. Meijer, MD, PhD |
| author_sort | Nika Kotnik, MD |
| collection | DOAJ |
| format | Article |
| id | doaj-art-1505d6ec01294cc69fed56a17b565d8a |
| institution | Kabale University |
| issn | 2352-5126 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj-art-1505d6ec01294cc69fed56a17b565d8a2025-08-20T03:25:12ZengElsevierJAAD Case Reports2352-51262025-07-016110010610.1016/j.jdcr.2025.03.021Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrumNika Kotnik, MD0Gilles F.H. Diercks, MD, PhD1Hilde Jalving, MD, PhD2Geke A.P. Hospers, MD, PhD3Sjoukje F. Oosting, MD, PhD4Michel van Kruchten, MD, PhD5T. Jeroen N. Hiltermann, MD, PhD6Maria C. Bolling, MD, PhD7Jeroen Bremer, PhD8Barbara Horváth, MD, PhD9Joost M. Meijer, MD, PhD10Department of Dermatology, University of Groningen, University Medical Center Groningen, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), Groningen, the Netherlands; Division of Experimental Allergy and Immunodermatology, University of Oldenburg, Oldenburg, GermanyDepartment of Dermatology, University of Groningen, University Medical Center Groningen, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), Groningen, the Netherlands; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Dermatology, University of Groningen, University Medical Center Groningen, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), Groningen, the NetherlandsDepartment of Dermatology, University of Groningen, University Medical Center Groningen, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), Groningen, the NetherlandsDepartment of Dermatology, University of Groningen, University Medical Center Groningen, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), Groningen, the NetherlandsDepartment of Dermatology, University of Groningen, University Medical Center Groningen, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), Groningen, the Netherlands; Correspondence to: Joost M. Meijer, MD, PhD, Department of Dermatology, University Medical Center Groningen, Hanzeplein 1, Groningen, 9700 RB, the Netherlands.http://www.sciencedirect.com/science/article/pii/S2352512625001456autoimmune bullous diseasebullous pemphigoidcheckpoint inhibitorimmune-related adverse effectimmunotherapy |
| spellingShingle | Nika Kotnik, MD Gilles F.H. Diercks, MD, PhD Hilde Jalving, MD, PhD Geke A.P. Hospers, MD, PhD Sjoukje F. Oosting, MD, PhD Michel van Kruchten, MD, PhD T. Jeroen N. Hiltermann, MD, PhD Maria C. Bolling, MD, PhD Jeroen Bremer, PhD Barbara Horváth, MD, PhD Joost M. Meijer, MD, PhD Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum JAAD Case Reports autoimmune bullous disease bullous pemphigoid checkpoint inhibitor immune-related adverse effect immunotherapy |
| title | Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum |
| title_full | Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum |
| title_fullStr | Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum |
| title_full_unstemmed | Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum |
| title_short | Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum |
| title_sort | pemphigoid diseases as immune related adverse effect following immune checkpoint inhibitors a clinical case series of a diverse spectrum |
| topic | autoimmune bullous disease bullous pemphigoid checkpoint inhibitor immune-related adverse effect immunotherapy |
| url | http://www.sciencedirect.com/science/article/pii/S2352512625001456 |
| work_keys_str_mv | AT nikakotnikmd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT gillesfhdiercksmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT hildejalvingmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT gekeaphospersmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT sjoukjefoostingmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT michelvankruchtenmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT tjeroennhiltermannmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT mariacbollingmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT jeroenbremerphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT barbarahorvathmdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum AT joostmmeijermdphd pemphigoiddiseasesasimmunerelatedadverseeffectfollowingimmunecheckpointinhibitorsaclinicalcaseseriesofadiversespectrum |